Original price was: $119.99.$99.98Current price is: $99.98.
Researched Benefits:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Our BPC-157 5mg and TB-500 5mg blend is designed to support research into tissue repair and inflammation reduction. This blend leverages the powerful properties of both peptides to promote healing and regeneration, making it a valuable tool for studies in muscle and joint recovery.
Key Features:
Applications:
| CAS No. | 137525-51-0 |
|---|---|
| Purity | ≥99% |
| Molecular Formula | C62H98N16O22 |
| Molecular Weight | 1419.535 g/mol |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for 24 months at -20°C in lyophilized form. After reconstitution, store at 4°C for up to 2 weeks or -20°C for up to 6 months. |
| Appearance | White crystalline powder |
| Shipping Conditions | Shipped at room temperature. Upon receipt, store at -20°C |
| Regulatory/Compliance | Complies with research use only standards. Not for drug, household, or other uses. |
| Safety Information | Refer to MSDS; handle according to established laboratory safety procedures |
Consider these supplementary peptides for a comprehensive research approach.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Altamonte Springs, FL. 32714
Sign up to our newsletter to get updated information, news and insights.
Reviews
There are no reviews yet.